Brief: Neuroscientific Biopharmaceuticals Says Paul Rennie Appointed As Interim CEO
22/11/2022 22:45
Nov 23 (Reuters) - NeuroScientific Biopharmaceuticals
Ltd NSB.AX :
* NON-EXECUTIVE CHAIRMAN PAUL RENNIE HAS BEEN APPOINTED AS
INTERIM
CEO
* PAUL RENNIE WILL CONTINUE TO ACT AS CHAIRMAN, WHILST
STEPPING
INTO INTERIM CEO ROLE
Source text for Eikon: ID:nASXbF3yFM
Further company coverage: NSB.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Miro Sciences
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO